Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Recruiting 11Completed 11Terminated 8Active not recruiting 5Unknown 3Withdrawn 2Not yet recruiting 2Suspended 1

Sponsor Class

NETWORK 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 87Thoracic 8Gastrointestinal 7Genitourinary 6Head & Neck 5Gynecologic 5Sarcoma 2Dermatologic 2Plasma cell 1Other solid neoplasm 1CNS 1

Conditions

Sarcoma 47Osteosarcoma 15Dendritic Cell Sarcoma, Interdigitating 12Bone Neoplasms 11Rhabdomyosarcoma 9Gastrointestinal Stromal Tumors 8Sarcoma, Ewing 5Melanoma 5Sarcoma, Kaposi 4Recurrence 4Neurofibrosarcoma 4Neoplasms 4Liposarcoma 4Breast Neoplasms 4Uterine Cervical Neoplasms 3Squamous Cell Carcinoma of Head and Neck 3Sarcoma, Alveolar Soft Part 3Ovarian Neoplasms 3Colorectal Neoplasms 3Triple Negative Breast Neoplasms 2Thyroid Neoplasms 2Sarcoma, Synovial 2Pancreatic Neoplasms 2Neurofibromatosis 1 2Neuroblastoma 2Medulloblastoma 2Lung Neoplasms 2Leiomyosarcoma 2Leiomyoma 2Hodgkin Disease 2

Interventions

fludarabine 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Not yet recruiting × Triple Negative Breast Neoplasms × Sarcoma × Clear all
NCT07630961 2026-06-05

Phase I Study of JFI447 [68Ga]Ga-DFC413 and Comparison to FFG233 [68Ga]Ga-NNS309 in Patients With Solid Tumors

Novartis

Phase 1 Not yet recruiting
66 enrolled
BreastGastrointestinalSarcomaThoracic

Carcinoma, Non-Small-Cell Lung, Sarcoma, Colorectal Neoplasms, Triple Negative Breast Neoplasms

NCT07297667 2026-05-12

GCAR1, a Chimeric Antigen Receptor (CAR) T-CELL Therapy for Relapsed/Refractory GPNMB-Expressing Solid Tumours

Canadian Cancer Trials Group

Phase 1 Not yet recruiting
30 enrolled
BreastGenitourinarySarcoma

Carcinoma, Renal Cell, Sarcoma, Alveolar Soft Part, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡